Navigation Links
Baumann Lab defines proteins that distinguish chromosome ends from DNA double-strand breaks

Peter Baumann, Ph.D., Assistant Investigator, and Nancy Bae, Ph.D., Postdoctoral Research Associate in the Baumann Lab, have published a paper offering insight into the way cells protect chromosome ends from misguided repair.

Published in tomorrow's issue of Molecular Cell, their paper entitled "A RAP1/TRF2 Complex Inhibits Non-Homologous End Joining at Human Telomeric DNA Ends" employed a biochemical assay for double-strand break repair to define the minimal requirements for the protection of telomeric DNA at the ends of chromosomes.

"Surprisingly, we found that neither long single-stranded overhangs nor t-loop formation is essential to prevent illegitimate repair of telomeric ends," said Dr. Bae. "Instead, a short tandem array of telomeric repeats bound by a Rap1/Trf2 complex is sufficient to impede non-homologous end joining in a highly directional manner."

It has long been understood that chromosome ends are distinct from DNA double-strand breaks and that the cellular machinery that repairs DNA breaks does not act on telomeres. But how repair factors are prevented from acting at chromosome ends has been a hotly debated issue. Over the past decade, several telomeric complexes and structures have been identified and proposed to protect chromosome ends, but conclusive evidence that any of these are required for protection has been lacking.

"We set out to define the minimal requirements that would allow the DNA repair machinery to distinguish a chromosome end from a break," said Dr. Baumann. "By establishing an in vitro assay for chromosome end protection and by implicating specific proteins, we have opened the door to elucidate the mechanism by which RAP1/TRF2 inhibits double-strand break repair at chromosome ends."

"These findings are important for establishing a better understanding of tumor development," said Robb Krumlauf, Ph.D., Scientific Director. "Genomic instability and gross chromosomal rearrangements are a
'"/>

Source:Stowers Institute for Medical Research


Page: 1 2

Related biology news :

1. Study defines effective microbicide design for HIV/AIDS prevention
2. New, automated tool successfully classifies and relates proteins in unprecedented way
3. UWs Rosetta software to unlock secrets of many human proteins
4. Global analysis of membrane proteins
5. UNC plant researchers discover proteins interact to form hair-trigger protection against invaders
6. Mad cow proteins successfully detected in blood
7. Researchers develop new method for facile identification of proteins in bacterial cells
8. Hopkins scientists uncover tags that force proteins to cell surface
9. Researchers create functioning artificial proteins using natures rules
10. UCSD discovery may provide novel method to generate medically useful proteins
11. Prostate cancer uses Wnt signaling proteins to promote growth of bone tumors
Post Your Comments:
(Date:5/16/2013)... 16, 2013 Integrated Biometrics patented LES ... custom thin film transistor camera introduces Sherlock, a ... image in the smallest and lightest form factor ... F Mobile ID FAP 45, Certified scanner is ... size and weight when compared to optical scanners. ...
(Date:5/16/2013)... 23 million years old give unprecedented insight into ... of the most species-rich groups among the modern ... Bettina Reichenbacher from the Division of Paleontology and ... Sciences at Ludwig-Maximilians-Universitaet (LMU) in Munich / Germany ... which they assign to the group of bony ...
(Date:5/16/2013)... (GWA), where the entirety of an individual,s DNA is ... which can cause health problems is a massively useful ... pose major ethical problems if used incorrectly, say new ... published on line today (16 May 2013) in the ... based on whole genome and on exome* sequencing and ...
Breaking Biology News(10 mins):Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2
... awarded today at the IOF WCO-ECCEO10 Congress in Florence ... award honours an individual researcher who has significantly advanced ... work. It underlines an important aspect of IOF,s mission ... to promote medical innovation, scientific excellence and improved care. ...
... director of the Walter and Eliza Hall Institute from ... in the institute,s Molecular Genetics of Cancer division. ... Professor Doug Hilton, said he was delighted Professor Cory ... institute are immensely proud of this latest of Suzanne,s ...
... -- (May 6, 2010) -- With thousands of scientists across ... to fight disease, there,s a growing emphasis on finding the ... research from Rice University and the University of Cambridge suggests ... role in hematopoietic stem cells (HSCs), the self-renewing cells the ...
Cached Biology News:Suzanne Cory becomes first-elected woman president of AAS 2Stem cells: In search of a master controller 2
(Date:5/17/2013)... May 17, 2013 - Elsevier, a world-leading provider of ... announced the publication of a recent study in ... human blastocysts showing that those with an abnormal chromosomal ... they have developed to blastocysts, thereby classifying the risk ... study the same group has undertaken a retrospective study, ...
(Date:5/17/2013)... 2013  Cellular Biomedicine Group (OTCQB: CBMG) today ... the total projected enrollment required for its Phase ... efficacy of the medical technology haMPC (Human Adipose-derived ... To date the trial has had no Severe ... I open label clinical research trial for KOA, ...
(Date:5/17/2013)... Men’s skin is biologically different than women’s skin,( says skin ... known to react more aggressively when hormones change, and acne ... other acne causing factors like P.acnes bacteria and excess dirt ... unsightly acne scars. Adult acne treatment, Probiotic Action shares new ... to reduce and prevent acne scarring. , In order to ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 IAC Industries wants ... a start up laboratory needing to set up and furnish ... to a larger facility within a year’s time. How does ... that the laboratory is temporary? What is efficient and cost-effective? ... modular workstations from IAC Industries. The planners at DisperSol determined ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2
... /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ... of a series of new, proprietary Quill(TM) SRS ... invasive, gynecology procedures, including hysterectomies and myomectomies. In ... the United States of which approximately 130,000 were ...
... , , SAN DIEGO, Aug. ... scheduled to present at the Canaccord Adams 29th Annual Global Growth ... 2:00 p.m. Eastern Time. , , (Logo: ... these presentations will be accessible on the Company,s website at ...
... N.J., Aug. 4 DOR BioPharma, Inc., (OTC Bulletin ... company, announced today that the Office of Orphan Products ... (FDA) has granted Orphan Drug Designation to Oral BDP ... symptoms associated with chronic Graft-versus-Host disease (cGVHD) in patients ...
Cached Biology Technology:Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 4Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 5Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 6Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference 2DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD 2DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD 3DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD 4DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD 5DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD 6
... This DuoSet ELISA Development kit contains ... of sandwich ELISAs to measure natural and ... supernates and serum. Each kit contains sufficient ... 96-well plates, provided that the following conditions ...
Conjugation services for Antibodies, Proteins, Oligos, Peptides, Beads, bioconjugation, antibody-oligonucleotide, LNA peptide, LNA protein, LNA antibody, HRP, Alkaline phosphatase, phycoerythrin, FIT...
Blimp-1 (H-150)...
SCP-1 (P-17)...
Biology Products: